Journal
ANALYST
Volume 146, Issue 13, Pages 4357-4364Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1an00556a
Keywords
-
Categories
Funding
- National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA) (Thailand) [P-1751330, P-1851652]
- National Nanotechnology Center (NANOTEC)
- National Science and Technology Development Agency (NSTDA)
Ask authors/readers for more resources
The study developed a versatile fluorescence-electrochemical aptasensor for the quantification of GHSA using a GO-Pb complex probe, showing a linear relationship and detection limits. The platform demonstrated good selectivity and stability, with potential applications in clinical sample analysis.
Monitoring of glycated human serum albumin (GHSA) as a glycemic marker for screening and monitoring of diabetes mellitus is widely practiced for patients with conditions that affect red blood cells. In this study, a complex comprising Pb ions adsorbed on graphene oxide (GO-Pb) was fabricated and utilized as a versatile probe in a fluorescence-electrochemical aptasensor for GHSA quantification. To simplify the aptasensor, the GO-Pb complex probe was prepared via an ion adsorption process. After modification with a fluorophore-labeled aptamer, the GO-Pb complex served as an excellent energy acceptor in fluorescence-based analysis, as well as generating a high current in the electrochemical transducer. Additionally, the proposed platform can detect GHSA via the dual technique from a single sample, allowing for precise and accurate results. Under optimal conditions, the fluorescence-electrochemical aptasensor exhibited a linear relationship with GHSA concentrations from 0.001 to 80 mu g mL(-1) and from 0.005 to 10 mu g mL(-1) for fluorescence and electrochemical detection, respectively. The corresponding detection limits were 8.80 ng mL(-1) and 0.77 ng mL(-1), respectively. The proposed aptasensor additionally displayed good selectivity and excellent stability. Moreover, its successful application in the analysis of clinical samples further demonstrated its utility. Therefore, the proposed platform has significant potential as a novel, facile, highly responsive, and low-cost monitoring method for the development of diabetes mellitus diagnostic devices intended for a clinical setting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available